Advanced search
Publication Cover
International Journal of Hyperthermia Volume 6, 1990 - Issue 3
Submit an article Journal homepage
19
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin

R. Engelhardt Department of Medical Oncology, University of Freiburgh Medical School, Freiburg i Br, FRG
,
U. Müller Department of Medical Oncology, University of Freiburgh Medical School, Freiburg i Br, FRG
,
R. Weth-Simon Department of Medical Oncology, University of Freiburgh Medical School, Freiburg i Br, FRG
,
H. A. Neumann Department of Medical Oncology, University of Freiburgh Medical School, Freiburg i Br, FRG
&
G. W. Lühr Department of Medical Oncology, University of Freiburgh Medical School, Freiburg i Br, FRG
Pages 511-515 | Received 10 May 1989, Accepted 05 Sep 1989, Published online: 09 Jul 2009

References

  • Alberts D. S., Peng Y., Chen H. S., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–461
  • Barlogie B., Corry P. M., Drewinko B. In viro thermochemotherapie of human cancer cells with cis-dichlorodiam-mineplatinum(II) and mitomycin C. Cancer Research 1980; 40: 1165–1168
  • Dahl O., Mella O. Timing and sequence of hyperthermia and drugs. Hyperthermic Oncology. 26 July 1984. Aarhus, Denmark 1984; Vol. I: 425–428, Proceedings of the 4th International Symposium on Hyperthermic Oncology
  • Douple E. B., Strohbehn J. S., DeSieyes D. C., Alborough D. P., Trembley B. S. Therapeutic potentiation of cis-dichlorodiammineplatinum(II) and radiation of by interstitital microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph 1982; 61: 251–262
  • Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 136–203
  • Gerner R. E., Moore G. E., Dickey C. Combination chemotherapy in disseminated melanoma and other solid tumors in adults. Oncology 1975; 31: 22–30
  • Goodnight J. E., Jr, Moseley H. S., Eilber F. R., Sarna G., Morton D. L. Cis-dich]orodiamrnineplatinum(H) alone and combined with DTIC for treatment of disseminated malignant melanoma. Cancer Treatment Report 1979; 63: 2005–2007
  • Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
  • Hahn G. M. Hyperthermia and Cancer. Plenum, New York 1982
  • Honess D. J. Animal models in the evaluation of therapeutic gain of thermochemotherapy. Proceedings of the 13th International Congress of Chemotherapy, Vienna, K. H. Spitzy, et al. 1983; 273/15–273/18
  • Honess D. J., Bleehen N. M. Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours. International Journal of Hyperthermia 1985; 1: 57–68
  • Marmor J. B. Interactions of hyperthermia and chemotherapy in animals. Cancer Research 1979; 39: 2269–2276
  • Mastrangelo M. J., Baker A. R., Katz H. R. Cutaneous Melanoma. Cancer, V. T. De Vita, S. Hellmann, S. Rosenberg. Lippincott, Philadelphia 1985; 1371–1422
  • Mella O., Erdcsen R., Dahl O., Laerum O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. European Journal of Clinical Oncology 1987; 23(4)365–373
  • Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
  • Neumann H. A., Engelhardt R., Fabricius H. A., Stahn R., Löhr G. W. Klinisch-chemische Untersuchungen an Tumorpatienten unter Zytostatika-und Ganzkörper-hyperthermiebehandlung. Klinische Wochenschrifl 1979; 57: 1311–1315
  • Neumann H. A., Fiebig H. H., Löhr G. W., Engelhardt R. Effects of cytostatic drugs and 40·5°C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice. Journal of the National Cancer Institute 1985; 75: 1059–1066
  • Wallner K. E., Li G. C. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin-C and cisplatin. Cancer Research 1987; 47: 493–495

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.